Director Cheryl Cohen to not stand for reelection at MEI Pharma's 2023 annual meeting
Lite Strategy, Inc.
Cheryl L. Cohen informed the board she will not stand for re-election at the fiscal year 2023 annual meeting, effective when her term expires.
Her decision is not due to any disagreement with the company's operations, policies, or practices.
Following the meeting and the earlier decision by Dr. White not to stand, the board will be reduced to seven members with no immediate replacement planned.
The board is considering a successor to the audit committee after the annual meeting; no formal decision made.
On October 4, 2022, Cheryl L. Cohen, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Audit Committee of the Board (the “Committee”), informed the Company that she has decided not to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Cheryl L. Cohen departed as Director at Lite Strategy, Inc..
Action
decided not to stand for reelection
Role
Director
Exact text from the filing
On October 4, 2022, Cheryl L. Cohen, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Audit Committee of the Board (the “Committee”), informed the Company that she has decided not to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.